Now, it’s worth noting Stock Advisor’s total average return is 973 % — a market-crushing outperformance compared to 195% for ...

What Happened? Shares of medical technology company Stryker (NYSE:SYK) jumped 4.1% in the afternoon session after analyst firm Raymond James upgraded the stock to "Outperform" from "Market Perform" ...

Stryker SYK is well-poised for growth, backed by a robust robotic arm-assisted surgery platform, Mako, and a diversified product portfolio. An improvement in price also buoys optimism. Shares of this ...

Stryker (NYSE: SYK) has outperformed the market over the past 10 years by 1.46% on an annualized basis producing an average annual return of 14.57%. Currently, Stryker has a market capitalization of ...

Stryker offers above-average revenue growth, robust margin leverage, and a compelling valuation relative to med-tech peers ...

Both companies are high-quality MedTech leaders, but their upside profiles diverge. Stryker’s diversification, consistent ...

Stryker builds an ASC ecosystem that drives growth, but margin pressure persists. Click here to read my latest analysis of ...

This was the stock's second consecutive day of losses.

Stryker (NYSE: SYK), the medical devices powerhouse, has recently launched its Sync Badge—a hands-free, wearable communication device designed to enhance collaboration among healthcare teams. This new ...

Investors looking for stocks in the Medical - Products sector might want to consider either Envista (NVST) or Stryker (SYK). But which of these two stocks offers value investors a better bang for ...